US Stock MarketDetailed Quotes
BIIB Biogen
- 196.218
- -0.582-0.30%
Trading Apr 16 13:34 ET
28.52BMarket Cap24.62P/E (TTM)
197.730High195.060Low381.08KVolume196.200Open196.800Pre Close74.92MTurnover0.26%Turnover Ratio24.62P/E (Static)145.36MShares319.76052wk High1.93P/B28.41BFloat Cap195.06052wk Low--Dividend TTM144.81MShs Float480.180Historical High--Div YieldTTM1.36%Amplitude2.625Historical Low196.601Avg Price1Lot Size
About Biogen Company
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Company Profile
SymbolBIIB
Company NameBiogen
Listing DateSep 17, 1991
Issue Price15.00
Founded1978
CEOMr. Christopher A. Viehbacher
MarketNASDAQ
Employees7570
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address225 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-679-2000
Websitehttp://www.biogen.com
Company Executives
- Name
- Position
- Salary
- Christopher A. Viehbacher
- Director, President and Chief Executive Officer
- 30.49M
- Susan H. Alexander
- Executive Vice President and Chief Legal Officer
- 6.79M
- Dr. Ginger Gregory, PhD
- Executive Vice President and Chief Human Resources Officer
- 5.08M
- Robin C. Kramer
- Senior Vice President and Chief Accounting Officer
- --
- Michael R. Mcdonnell
- Executive Vice President and Chief Financial Officer
- 7.21M
- Dr. Priya Singhal, M.D.,M.P.H.
- Executive Vice President and Head of Development
- --
- Nicole Murphy
- Executive Vice President, Pharmaceutical Operations and Technology
- 4.93M
- Dr. Jane Grogan, PhD
- Executive Vice President, Head of Research
- --
- Adam Keeney, PhD
- Executive Vice President, Head of Corporate Development
- --
- Rachid Izzar
- Executive Vice President, Global Product Strategy and Commercialization
- --
- Caroline D. Dorsa
- Chairman of the Board
- 425.41K
- Monish D. Patolawala
- Director
- --
- William A. Hawkins, III
- Independent Director
- 410.41K
- Susan Langer
- Independent Director
- --
- Dr. Stephen A. Sherwin, M.D.
- Independent Director
- 460.41K
- Dr. Maria C. Freire, PhD
- Independent Director
- 351.57K
- Dr. Eric K. Rowinsky,M.D.
- Independent Director
- 410.41K
- Jesus B. Mantas
- Independent Director
- 410.41K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
